Literature DB >> 12087526

Prospective study of measles in hospitalized, human immunodeficiency virus (HIV)-infected and HIV-uninfected children in Zambia.

William J Moss1, Mwaka Monze, Judith J Ryon, Thomas C Quinn, Diane E Griffin, Felicity Cutts.   

Abstract

Measles in persons coinfected with human immunodeficiency virus (HIV) has been reported to be unusual in its presentation and frequently fatal. To determine the effect of HIV coinfection on the clinical features and outcome of measles, a prospective study of hospitalized children with measles was conducted between January 1998 and October 2000 in Lusaka, Zambia. One-sixth (17%) of 546 children hospitalized with laboratory-confirmed measles were coinfected with HIV. One-third of the HIV-infected children hospitalized with confirmed measles were <9 months old, compared with 23% of HIV-uninfected children (P=.03). Few differences in clinical manifestations, complications, or mortality were found between HIV-infected and HIV-uninfected children with measles. HIV-infected children constitute a significant proportion of children hospitalized with measles in countries with high HIV prevalence and are more likely to be younger than the age for routine measles immunization.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12087526     DOI: 10.1086/341248

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  23 in total

Review 1.  Immune containment and consequences of measles virus infection in healthy and immunocompromised individuals.

Authors:  Sallie R Permar; Diane E Griffin; Norman L Letvin
Journal:  Clin Vaccine Immunol       Date:  2006-04

Review 2.  Measles in the United Kingdom: can we eradicate it by 2010?

Authors:  Perviz Asaria; Eithne MacMahon
Journal:  BMJ       Date:  2006-10-28

Review 3.  Measles virus, immune control, and persistence.

Authors:  Diane E Griffin; Wen-Hsuan Lin; Chien-Hsiung Pan
Journal:  FEMS Microbiol Rev       Date:  2012-03-13       Impact factor: 16.408

Review 4.  Biological feasibility of measles eradication.

Authors:  William J Moss; Peter Strebel
Journal:  J Infect Dis       Date:  2011-07       Impact factor: 5.226

5.  Assessment of the epidemiology and burden of measles in Southern Mozambique.

Authors:  Inácio Mandomando; Denise Naniche; Marcela F Pasetti; Lilian Cuberos; Sergi Sanz; Xavier Vallès; Betuel Sigauque; Eusébio Macete; Delino Nhalungo; Karen L Kotloff; Myron M Levine; Pedro L Alonso
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

6.  The burden of vaccine-preventable diseases among HIV-infected and HIV-exposed children in sub-Saharan Africa: a systematic review and meta-analysis.

Authors:  Olatunji O Adetokunboh; Ajibola Awotiwon; Duduzile Ndwandwe; Olalekan A Uthman; Charles S Wiysonge
Journal:  Hum Vaccin Immunother       Date:  2019-05-22       Impact factor: 3.452

7.  Functional and phenotypic changes in circulating lymphocytes from hospitalized zambian children with measles.

Authors:  Judith J Ryon; William J Moss; Mwaka Monze; Diane E Griffin
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

8.  Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques.

Authors:  Chien-Hsiung Pan; Nitya Nair; Robert J Adams; M Christine Zink; Eun-Young Lee; Fernando P Polack; Manmohan Singh; Derek T O'Hagan; Diane E Griffin
Journal:  Clin Vaccine Immunol       Date:  2008-02-20

9.  HIV-1 infection in Zambian children impairs the development and avidity maturation of measles virus-specific immunoglobulin G after vaccination and infection.

Authors:  Nitya Nair; William J Moss; Susana Scott; Nanthalile Mugala; Zaza M Ndhlovu; Kareem Lilo; Judith J Ryon; Mwaka Monze; Thomas C Quinn; Simon Cousens; Felicity Cutts; Diane E Griffin
Journal:  J Infect Dis       Date:  2009-10-01       Impact factor: 5.226

10.  Emergence and re-emergence of viral diseases of the central nervous system.

Authors:  Diane E Griffin
Journal:  Prog Neurobiol       Date:  2009-12-10       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.